Viral potentiation of chemical toxins in the experimental syndrome of hypoglycemia, encephalopathy, and visceral fatty degeneration.
D000348:Aflatoxins; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001927:Brain Diseases / Q000139:chemically induced / Q000209:etiology* / Q000382:microbiology; D004357:Drug Synergism; D004769:Enterovirus Infections / Q000150:complications*; D005231:Fatty Acids, Unsaturated; D005234:Fatty Liver / Q000139:chemically induced / Q000209:etiology* / Q000382:microbiology; D006003:Glycogen / Q000032:analysis; D001556:Hexachlorocyclohexane; D007003:Hypoglycemia / Q000139:chemically induced / Q000209:etiology* / Q000382:microbiology; D008099:Liver / Q000032:analysis / Q000473:pathology; D008574:Mengovirus; D051379:Mice; D008854:Microscopy, Electron; D008930:Mitochondria, Liver / Q000187:drug effects; D011078:Polychlorinated Biphenyls; D051381:Rats; D012202:Reye Syndrome / Q000209:etiology; D013577:Syndrome; D014118:Toxins, Biological; D014280:Triglycerides / Q000032:analysis; D014631:Valerates
D000348:Aflatoxins; D001786:Blood Glucose; D005231:Fatty Acids, Unsaturated; D014118:Toxins, Biological; D014280:Triglycerides; D014631:Valerates; D001556:Hexachlorocyclohexane; D006003:Glycogen; D011078:Polychlorinated Biphenyls